4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole
| Product Name |
4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole
|
| Product Code |
DA-E093-04
|
| Chemical name |
4-[(1E,3S,5Z,8R/S,10S)-3,11-Bis-{[tert-butyl(dimethyl)silyl]oxy}-2,6,10-trimethyl-undeca-1,5-dienyl]-2-methyl-1,3-thiazole
|
| Synonyms |
4-((1E,3S,5Z,10S)-3,11-bis((tert-butyldimethylsilyl)oxy)-2,6,10-trimethylundeca-1,5-dien-1-yl)-2-methylthiazole;
|
| Impurity |
NA
|
| CAS Number |
210690-85-0
|
| Alternate CAS # |
NA
|
| Molecular form |
C30H57NO2SSi2
|
| Appearance |
Colourless Oil
|
| Melting Point |
NA
|
| Mol. Weight |
552.02
|
| Storage |
2-8°C Refrigerator
|
| Solubility |
NA
|
| Stability |
NA
|
| Category |
chiral standards,pharmaceutical standards,impurities,metabolites,fine chemicals
|
| Boiling Point |
NA
|
| Applications |
An intermediate in the synthesis of Epothilones. Epothilones are polyketide natural products that inhibit cancer cells by a mechanism similar to paclitaxel, and also are effective against paclitaxel-resistant tumours. Epothilone D is in phase I clinical testing of in patients with advanced solid tumours. Epothilone D is a cytotoxic macrolide that stabilises malignant cells' microtubules and arrests mitosis, a characteristic it shares with other epothilones. They bind to the same hepatic sites as does paclitaxel (Taxol) in a 1:1 stoichiometric ratio of a, b-tubulin heterodimers.
|
| Dangerous Goods Info |
NA
|
| References |
NA
|
| Extra Notes |
NA
|
| Documents (MSDS) |
No Data Available
|
| Keywords |
NA |
